Walgreens’ Chawla named to apparel retailer’s board
COLUMBUS, Ohio — Walgreens’ e-commerce president Sona Chawla has been appointed to serve on the board of directors at specialty retail apparel chain Express.
Chawla, who will serve as a class-3 director and brings the number of directors on Express’ board to seven, also will serve on the Express’ compensation and governance committee. Chawla has lead Walgreens’ e-commerce business since January 2011. Prior to her role at Walgreens, she served in roles at Dell and Wells Fargo.
"I am pleased to welcome Sona to the board," Express board chairman, president and CEO Michael Weiss said. "Sona’s particular knowledge and experience in e-commerce, marketing, strategy and general management will be extremely beneficial to Express as we continue to deliver on our four pillars of growth, particularly e-commerce."
Q2 sales, comps up for Publix as stock price drops
LAKELAND, Fla. — Publix on Wednesday posted sales of $6.8 billion for second quarter 2012, up 3.2%. Comparable-store sales for the second quarter increased 1.9%.
The amounts are based on unaudited reports that will be filed Aug. 9 with the U.S. Securities and Exchange Commission, the grocer reported.
Effective Aug. 1, Publix’s stock price decreased from $22.70 per share to $22.00 per share. Publix stock is not publicly traded and is made available for sale only to current Publix associates and members of its board of directors.
"The economy continues to affect our results and stock price," Publix CEO Ed Crenshaw said. "During these difficult times, our associates remain focused on providing excellent customer service."
FDA approves ingestible sensor for medication adherence monitoring
REDWOOD CITY, Calif. — Big Doctor is watching you — to make sure you’re taking your drugs as prescribed, that is.
It’s not dystopian, but it sure sounds like the stuff of science fiction: The Food and Drug Administration approved Monday a tiny, ingestible sensor that can be integrated into drugs to monitor patients’ prescription drug adherence.
The sensor, made by Proteus Digital Health, is powered by contact with stomach fluid and works by transmitting a signal that determines the identity and timing of a drug’s ingestion to a patch worn on the skin. The patch then transmits the information to a mobile app, which can be accessed by clinicians and caregivers. The patch also collects such data as heart rate, body position and activity.
"The FDA validation represents a major milestone in digital medicine," Scripps Research Institute genomics professor Eric Topol said. "Directly digitizing pills, for the first time, in conjunction with our wireless infrastructure, may prove to be the new standard for influencing medication adherence and significantly aid chronic disease management."